Slideshow

April Research Update: Major Depressive Disorder

Author(s):

Mark L. Fuerst

Relapse in MDD is associated with morphologic brain changes; stopping exercise may increase depressive symptoms; and inflammatory biomarkers may predict which treatment-resistant MDD patients benefit from ECT.

Related Videos
Have A Nice Day Photo/AdobeStock
Tasphong/AdobeStock
Andrey/AdobeStock
brain research
pills
brain
depression
brain depression
Related Content
depression
March 19th 2025

Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression

Justin Allen, MD Lalangi Marasinghe, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
Justlight/AdobeStock
March 13th 2025

Lindus Health and Sooma Medical Launch Phase 3 Trial for Transcranial Direct Current Stimulation in Treating MDD

Megan McSweeney
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
yana136/AdobeStock
March 5th 2025

Ketamine, TMS Show Promise in Treatment-Resistant Depression in Older Adults

Megan McSweeney
depression
March 5th 2025

BLP-003 for Treatment-Resistant Depression: Phase 2b Patient Enrollment Completed

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.